PRODUCT DETAILS
- RLD: NAMENDA XR®
- Strength: Available in 7 mg, 14 mg, 21 mg, and 28 mg extended-release capsules
- Therapeutic Class: NMDA Inhibitor
PRODUCT DETAILS
| Strength | NDC Number | Saleable Unit | Wholesaler Numbers |
|---|---|---|---|
| 7 mg | 70436-054-04 | Bottle of 30 | Cardinal Health: 5751813 |
| McKesson: 2363158 | |||
| Amerisource: 10262223 | |||
| 14 mg | 70436-055-04 | Bottle of 30 | Cardinal Health: 5751821 |
| McKesson: 2363166 | |||
| Amerisource: 10262247 | |||
| 14 mg | 70436-055-06 | Bottle of 90 | Cardinal Health: 5751839 |
| McKesson: 2363174 | |||
| Amerisource: 10262216 | |||
| 21 mg | 70436-056-04 | Bottle of 30 | Cardinal Health: 5751847 |
| McKesson: 2363182 | |||
| Amerisource: 10262344 | |||
| 28 mg | 70436-057-04 | Bottle of 30 | Cardinal Health: 5751854 |
| McKesson: 2363190 | |||
| Amerisource: 10262254 | |||
| 28 mg | 70436-057-06 | Bottle of 90 | Cardinal Health: 5751862 |
| McKesson: 2363208 | |||
| Amerisource: 10262217 |
7 mg – Opaque buff capsule, with “YH” black imprint on the cap and “123” black imprint on the body.
14 mg Capsule – Opaque buff cap and opaque dark green body capsule, with “YH” black imprint on the cap and “124” black imprint on the body.
21 mg Capsule – Opaque white cap and opaque dark green body capsule, with “YH” black imprint on the cap and “125” black imprint on the body.
28 mg Capsule – Dark green opaque capsule, with “YH” white imprint on the cap and “126” white imprint on the body.
Storage: Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in a tightly closed container as defined in the USP with a child-resistant closure.
We have been made aware of recent scams that offer false employment opportunities or request financial commitments purportedly on behalf of Slate Run Pharmaceuticals. Unsuspecting job seekers have reported receiving unsolicited contacts such as e-mails and phone calls which may request personal information or offers of employment. Please note that these communications are fraudulent and are not affiliated with Slate Run Pharmaceuticals. Slate Run Pharmaceuticals never requires a financial deposit for employment consideration nor do we offer unsolicited employment packages.
You can reach out to Slate Run Pharmaceuticals at http://www.slaterunpharma.com/get-in-touch/. If you receive a suspicious proposal, please contact your local law enforcement agency for guidance.